| Molecular aspects of cancer chemopreventive and therapeutic efficacies of tea and tea polyphenols S Sur, CK Panda Nutrition 43, 8-15, 2017 | 96 | 2017 |
| miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression S Sur, R Steele, X Shi, RB Ray Cells 8 (11), 1455, 2019 | 86 | 2019 |
| Prevention of liver carcinogenesis by amarogentin through modulation of G 1 /S cell cycle check point and induction of apoptosis D Pal, S Sur, S Mandal, A Das, A Roy, S Das, CK Panda Carcinogenesis 33 (12), 2424-2431, 2012 | 76 | 2012 |
| Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy S Sur, RB Ray Cancers 12 (8), 2064, 2020 | 67 | 2020 |
| Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice S Sur, D Pal, R Roy, A Barua, A Roy, P Saha, CK Panda Toxicology and Applied Pharmacology 300, 34-46, 2016 | 66 | 2016 |
| Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways S Sur, D Pal, S Mandal, A Roy, CK Panda The Journal of nutritional biochemistry 27, 32-42, 2016 | 61 | 2016 |
| Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract S Sur, H Nakanishi, C Flaveny, JE Ippolito, J McHowat, DA Ford, RB Ray Cell Communication and Signaling 17, 1-13, 2019 | 55 | 2019 |
| Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in cells of distant organ S Sur, M Khatun, R Steele, TS Isbell, R Ray, RB Ray International Journal of Molecular Sciences 22 (6), 3184, 2021 | 50 | 2021 |
| Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line D Pal, S Sur, R Roy, S Mandal, C Kumar Panda Journal of cellular physiology 234 (1), 825-836, 2019 | 44 | 2019 |
| Disrupting cholesterol esterification by bitter melon suppresses triple‐negative breast cancer cell growth SH Shim, S Sur, R Steele, CJ Albert, C Huang, DA Ford, RB Ray Molecular carcinogenesis 57 (11), 1599-1607, 2018 | 41 | 2018 |
| Bitter Melon Prevents the Development of 4-NQO–Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling S Sur, R Steele, R Aurora, M Varvares, KE Schwetye, RB Ray Cancer Prevention Research 11 (4), 191-202, 2018 | 37 | 2018 |
| Pongapin and Karanjin, furanoflavanoids of Pongamia pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by differential reactive oxygen species … R Roy, D Pal, S Sur, S Mandal, P Saha, CK Panda Phytotherapy Research 33 (4), 1084-1094, 2019 | 28 | 2019 |
| Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways S Sur, H Nakanishi, R Steele, RB Ray BMC cancer 19, 1-9, 2019 | 26 | 2019 |
| Long non‐coding RNA ELDR enhances oral cancer growth by promoting ILF 3‐cyclin E1 signaling S Sur, H Nakanishi, R Steele, D Zhang, MA Varvares, RB Ray EMBO reports 21 (12), e51042, 2020 | 24 | 2020 |
| Association between microRNA-373 and long noncoding RNA NORAD in hepatitis C virus-infected hepatocytes impairs wee1 expression for growth promotion S Sur, R Sasaki, P Devhare, R Steele, R Ray, RB Ray Journal of virology 92 (20), 10.1128/jvi. 01215-18, 2018 | 24 | 2018 |
| Circulatory exosomes from COVID-19 patients trigger NLRP3 inflammasome in endothelial cells S Sur, R Steele, TS Isbell, R Ray, RB Ray Mbio 13 (3), e00951-22, 2022 | 22 | 2022 |
| Inhibition of long noncoding RNA Linc‐Pint by hepatitis C virus in infected hepatocytes enhances lipogenesis M Khatun, S Sur, R Steele, R Ray, RB Ray Hepatology 74 (1), 41-54, 2021 | 22 | 2021 |
| Emerging role of lncRNA ELDR in development and cancer S Sur, RB Ray The FEBS Journal 289 (11), 3011-3023, 2022 | 18 | 2022 |
| Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model S Sur, D Pal, K Banerjee, S Mandal, A Das, A Roy, CK Panda Molecular carcinogenesis 55 (7), 1138-1149, 2016 | 18 | 2016 |
| Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy M Nazzal, S Sur, R Steele, M Khatun, T Patra, N Phillips, J Long, R Ray, ... Hepatology 72 (2), 379-388, 2020 | 16 | 2020 |
